KRAZATI
NDC 80739-812, adagrasib, tablet, coated, from Mirati Therapeutics, Inc.
- Product NDC
- 80739-812
- Status
- Listed
- Labeler
- Mirati Therapeutics, Inc
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216340
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80739-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADAGRASIB200 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80739-812-12 | 80739081212 | 1 BOTTLE in 1 CARTON (80739-812-12) / 120 TABLET, COATED in 1 BOTTLE |
| 80739-812-18 | 80739081218 | 1 BOTTLE in 1 CARTON (80739-812-18) / 180 TABLET, COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0b8bf078-34c2-4f45-9012-38a8ac082b01
Use it
Look up 80739-812 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80739-812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80739-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.